666: When Vision is the Plus Multiplier | Manmeet Soni, CFO, Reata Pharmaceuticals
It’s a phrase that has historically never roamed far beyond the corridors of pharmaceutical companies, but now—thanks to COVID 19—the term “clinical trials” has entered the vocabulary of the public at large.
Perhaps at no time in history have the “trials” that pharma companies use to generate data on the safety of a particular drug, vaccine, or treatment been as heavily scrutinized—and at no previous time has CFO Manmeet Soni of Reata Pharmaceuticals believed that the processes and approaches that govern Reata’s “trial design” have been more ripe for innovation.
“Our learnings from the past 9…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.